Researcher in a UTHealth Houston lab stands with arms crossed in front of a glass wall, while team members in blue lab coats conduct experiments at benches with scientific equipment in the background.

UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation

CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly. The dual-payload antibody-drug conjugate technology was originally created by…

Dr. Kyoji Tsuchikama

Tsuchikama wins Dunn Collaborative Research Award

The Gulf Coast Consortia announced that Kyoji Tsuchikama, PhD, associate professor in the Texas Therapeutics Institute at the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, is a 2025 winner of the John S. Dunn Foundation…

Pages